Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Biomarker Signature-Supported Antibiotic Treatment Decisions in Intensive Care Units

NCT07481773 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT07481773
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07481773 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Biomarker Signature-Supported Antibiotic Treatment Decisions in Intensive Care Units
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Not applicable
Overall status
Recruiting
Start date
May 13, 2025
Completion date
August 31, 2028
Enrollment
1,200 (estimated)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

intensive care unit (icu) admission